ANDA 91279, held by Aiping Pharm Inc. Aripiprazole.
As of Nov 16, 2026, ANDA 91279 (Aripiprazole), held by Aiping Pharm Inc, was first approved by FDA on Jan 9, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 9, 2017 | Original application | Approved | None posted |
| Aripiprazole2MG · tablet;oral | Aripiprazole | Discontinued |
| Aripiprazole5MG · tablet;oral | Aripiprazole | Discontinued |
| Aripiprazole10MG · tablet;oral | Aripiprazole | Discontinued |
| Aripiprazole15MG · tablet;oral | Aripiprazole | Discontinued |
| Aripiprazole20MG · tablet;oral | Aripiprazole | Discontinued |
| Aripiprazole30MG · tablet;oral | Aripiprazole | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters